CSPC pharmaceutical buys HK$26.5m in shares for employee scheme

On October 17, 2025, CSPC Pharmaceutical Group Limited's trustee purchased 3,000,000 shares on-market for its restricted share award scheme. This transaction, representing approximately 0.026% of the company's existing total shares in issue, was executed at an average price of HK$8.8634 per share.

The total consideration for this purchase amounted to approximately HK$26,590,000. Following this acquisition, the balance of shares held by the trustee for the scheme now stands at 117,000,000 shares.

The board retains the discretion to determine the number of shares awarded to selected participants and the quantity of shares to be further purchased on-market under the scheme, indicating ongoing management of the award program.